OVID icon

Ovid Therapeutics
OVID

Overview Fund Trends Analyst Outlook Journalist POV

47 hedge funds and large institutions have $16.5M invested in Ovid Therapeutics in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

61% less capital invested

Capital invested by funds: $41.9M → $16.5M (-$25.4M)

Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.87M
2
+$348K
3
+$192K
4
Renaissance Technologies
Renaissance Technologies
New York
+$133K
5
Two Sigma Investments
Two Sigma Investments
New York
+$114K

Top Sellers

1
-$5.76M
2
-$2.41M
3
-$1.26M
4
DCM
Driehaus Capital Management
Illinois
-$1.2M
5
GPCM
Granite Point Capital Management
Massachusetts
-$634K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$49K
27
$46K
28
$40K
29
$39K
30
$38K
31
$36K
32
$33K
33
$26K
34
$26K
35
$24K
36
$23K
37
$21K
38
$19K
39
$17K
40
$9K
41
$5K
42
$5K
43
$2K
44
$1K
45
$1K
46
$605
47
–
48
–
49
–
50
–
1
2
3